Legal Opinion
In re: MDL 2700 Genentech
Court of Appeals for the Tenth Circuit
Decided May 29, 2020No. 19-5035Published
1Opinion of the Court
FILED United States Court of Appeals Tenth Circuit PUBLISH May 29, 2020 UNITED STATES COURT OF APPEALS Christopher M. Wolpert FOR THE TENTH CIRCUIT Clerk of Court _________________________________ In re: MDL 2700 Genentech Herceptin (Trastuzumab) Marketing and Sales Practice Litigation. -------------------------- TULSA CANCER INSTITUTE, PLLC, an Oklahoma Professional Limited Liability Company, n/k/a Oklahoma Cancer Specialists Management Company, LLC; OKLAHOMA ONCOLOGY & HEMATOLOGY, INC., an Oklahoma Corporation, d/b/a Cancer Care Associates; STATE OF OKLAHOMA EX REL. No. 19-5035 BOARD OF…
2Cases cited17 opinions
- Auer v. RobbinsSupreme Court of the United States · 1997
- Medtronic, Inc. v. LohrSupreme Court of the United States · 1996
- Jones v. Rath Packing Co.Supreme Court of the United States · 1977
- English v. General Electric Co.Supreme Court of the United States · 1990
- Wyeth v. LevineSupreme Court of the United States · 2009
12 more not listed; retrieve them via the Exa API.